What is Velos?
Founded in 1996 and headquartered in Fremont, California, Velos serves as a critical nexus for clinical trial management. The platform provides a comprehensive suite of tools designed to harmonize clinical, administrative, and financial data streams for investigators and academic leaders. By prioritizing workflow flexibility and data-driven research management, Velos empowers organizations to accelerate clinical innovation while maintaining rigorous compliance standards. Its market position is defined by a long-standing reputation for reliability in managing complex, multi-site research environments, making it an essential resource for the modern clinical trial ecosystem.
How much funding has Velos raised?
Velos has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Velos
PPP
Public-Private Partnership
What's next for Velos?
With the successful acquisition of $150K, Velos is well-positioned to scale its enterprise-grade solutions to meet the evolving demands of global clinical research. The company's strategic roadmap likely involves enhancing its interoperability features and expanding its suite of analytical tools to better support decentralized trial models. As the industry shifts toward more integrated, real-time data management, Velos is poised to leverage its established user base to drive further adoption of its research management software. The focus remains on maintaining its competitive edge through technological refinement and deepening its integration within the global academic and pharmaceutical research landscape.
See full Velos company page
